7 results
IDSA - Prophylaxis to Prevent First Episode of Opportunistic Disease in HIV-AIDS
 • Pneumocystis pneumonia (PCP)
Mycobacterium tuberculosis ... • Hepatitis A virus ... #OIs #HIVAIDS # ... IDSA #management ... #pharmacology
IDSA - Prophylaxis to Prevent First Episode of Opportunistic Disease in HIV-AIDS
 • Pneumocystis pneumonia (PCP)
Mycobacterium tuberculosis ... • Hepatitis A virus ... #OIs #HIVAIDS # ... IDSA #management ... #pharmacology
Summary table of the mechanism of action, side effect and contraindications of commonly used anti-coagulation drugs.
Summary table of ... anticoagulation #pharmacology ... #medications #doac ... #comparison #table ... #management #drugs
IDSA - Clinical Strategy to Build an Individualized Treatment Regimen for Multi-Drug Resistant Tuberculosis (MDR-TB)
 •
Resistant Tuberculosis ... are contacts of infectious ... #MDRTB #management ... antimicrobials #regimens #pharmacology ... #dosing #idsa #
IDSA Recommendations for Treating Mycobacterium Tuberculosis Infection and Disease in HIV-AIDS
Treating LTBI (to prevent TB disease)
Indications:
Mycobacterium Tuberculosis ... Please refer to the table ... Guidelines for dosing ... Prevention #Treatment #management ... #HIVAIDS #pharmacology
IDSA Recommendations for Preventing and Treating Disseminated Mycobacterium Avium Complex in HIV-AIDS
Preventing 1st Episode of Disseminated
please refer to Table ... 5 for dosing recommendation ... Prevention #Treatment #management ... opportunistic #infections ... #HIVAIDS #pharmacology
IDSA Recommendations for Treating Cytomegalovirus Infections in HIV-AIDS
Preventing CMV Disease:
 • CMV end-organ disease is best
best prevented by using ... intraocular levels of drug ... control of the infection ... Prevention #Treatment #management ... #HIVAIDS #pharmacology